Anika Therapeutics Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
43.65-0.78 (-1.76%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close44.43
Bid41.12 x 100
Ask0.00 x
Day's Range43.32 - 44.00
52wk Range34.02 - 54.96
1y Target EstN/A
Market Cap645.05M
P/E Ratio (ttm)19.05
Avg Vol (3m)117,432
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube4 days ago

    ETF’s with exposure to Anika Therapeutics, Inc. : October 20, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Anika Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to ANIK-US. Comparing the performance and risk of Anika Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Business Wire12 days ago

    Anika to Issue Third-Quarter 2016 Financial Results and Business Highlights on Wednesday, October 26

    Anika Therapeutics, Inc. today announced that the Company plans to issue its third-quarter 2016 financial results after the close of the market on Wednesday, October 26, 2016 and to hold a conference call the next day, Thursday, October 27, 2016, at 9:00 a.m.

  • Teva to Divest Actavis Generics' UK & Ireland Operations
    Zacks18 days ago

    Teva to Divest Actavis Generics' UK & Ireland Operations

    Teva Pharmaceutical Industries Ltd. (TEVA) announced that it has agreed to divest the U.K. and Ireland assets of Actavis Generics to Accord Healthcare, a subsidiary of Intas Pharmaceuticals Ltd.